Literature DB >> 18194380

How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity.

Ronald G Strauss1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18194380      PMCID: PMC2874902          DOI: 10.1111/j.1537-2995.2007.01592.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  48 in total

Review 1.  Data-driven blood banking practices for neonatal RBC transfusions.

Authors:  R G Strauss
Journal:  Transfusion       Date:  2000-12       Impact factor: 3.157

2.  Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?

Authors:  A R Franz; F Pohlandt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

3.  A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns.

Authors:  Vagner Castro; Hartmut Kroll; Andréa F Origa; Mônica A Falconi; Sílvia B D Marques; Sérgio T Marba; Renato Passini; Joyce M Annichino-Bizzacchi; Fernando F Costa; Sentot Santoso; Valder R Arruda
Journal:  Transfusion       Date:  2007-01       Impact factor: 3.157

4.  Commentary: is it safe to limit allogeneic red blood cell transfusions to neonates?

Authors:  Ronald G Strauss
Journal:  Neonatology       Date:  2007-11-16       Impact factor: 4.035

Review 5.  Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.

Authors:  P Mathew; G Young
Journal:  Haemophilia       Date:  2006-09       Impact factor: 4.287

6.  The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.

Authors:  Haresh Kirpalani; Robin K Whyte; Chad Andersen; Elizabeth V Asztalos; Nancy Heddle; Morris A Blajchman; Abraham Peliowski; Angel Rios; Meena LaCorte; Robert Connelly; Keith Barrington; Robin S Roberts
Journal:  J Pediatr       Date:  2006-09       Impact factor: 4.406

7.  Cost-effectiveness of a limited-donor blood program for neonatal red cell transfusions.

Authors:  P Hilsenrath; J Nemechek; J A Widness; D G Cordle; R G Strauss
Journal:  Transfusion       Date:  1999-09       Impact factor: 3.157

8.  Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.

Authors:  Karen M Pastos; William B Slayton; Lisa M Rimsza; Linda Young; Martha C Sola-Visner
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

9.  Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.

Authors:  H Donato; N Vain; P Rendo; N Vivas; L Prudent; M Larguía; J Digregorio; C Vecchiarelli; R Valverde; C García; P Subotovsky; C Solana; A Gorenstein
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

10.  Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates.

Authors:  Martha C Sola-Visner; Robert D Christensen; Alan D Hutson; Lisa M Rimsza
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

View more
  11 in total

Review 1.  Anaemia of prematurity: pathophysiology and treatment.

Authors:  Ronald G Strauss
Journal:  Blood Rev       Date:  2010-11       Impact factor: 8.250

2.  Treatment and Prevention of Neonatal Anemia.

Authors:  John A Widness
Journal:  Neoreviews       Date:  2008-11-01

3.  RBC storage and avoiding hyperkalemia from transfusions to neonates & infants.

Authors:  Ronald G Strauss
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

Review 4.  Is there a role for autologous/placental red blood cell transfusions in the anemia of prematurity?

Authors:  Ronald G Strauss; John A Widness
Journal:  Transfus Med Rev       Date:  2010-04

5.  A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs.

Authors:  Denison J Kuruvilla; John A Widness; Demet Nalbant; Robert L Schmidt; Donald M Mock; Peter Veng-Pedersen
Journal:  AAPS J       Date:  2015-05-28       Impact factor: 4.009

6.  Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants.

Authors:  Kevin J Freise; John A Widness; Peter Veng-Pedersen
Journal:  J Pharmacol Exp Ther       Date:  2009-10-06       Impact factor: 4.030

7.  A Mass Balance-Based Semiparametric Approach to Evaluate Neonatal Erythropoiesis.

Authors:  Denison J Kuruvilla; John A Widness; Demet Nalbant; Robert L Schmidt; Donald M Mock; Peter Veng-Pedersen
Journal:  AAPS J       Date:  2015-10-26       Impact factor: 4.009

8.  2008 Emily Cooley Memorial Lecture: lessons learned from pediatric transfusion medicine clinical trials . . . a little child shall lead them.

Authors:  Ronald G Strauss
Journal:  Transfusion       Date:  2009-06-10       Impact factor: 3.157

9.  Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities.

Authors:  Denison J Kuruvilla; John A Widness; Demet Nalbant; Robert L Schmidt; Donald M Mock; Guohua An; Peter Veng-Pedersen
Journal:  Pediatr Res       Date:  2017-01-18       Impact factor: 3.756

10.  Risk factors of transfusion in anemia of very low birth weight infants.

Authors:  Ga Won Jeon; Jong Beom Sin
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.